BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37652141)

  • 1. IL-13-induced STAT3-dependent signaling networks regulate esophageal epithelial proliferation in eosinophilic esophagitis.
    Marella S; Sharma A; Ganesan V; Ferrer-Torres D; Krempski JW; Idelman G; Clark S; Nasiri Z; Vanoni S; Zeng C; Dlugosz AA; Zhou H; Wang S; Doyle AD; Wright BL; Spence JR; Chehade M; Hogan SP
    J Allergy Clin Immunol; 2023 Dec; 152(6):1550-1568. PubMed ID: 37652141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of anoctamin 1 (ANO1) as a key driver of esophageal epithelial proliferation in eosinophilic esophagitis.
    Vanoni S; Zeng C; Marella S; Uddin J; Wu D; Arora K; Ptaschinski C; Que J; Noah T; Waggoner L; Barski A; Kartashov A; Rochman M; Wen T; Martin L; Spence J; Collins M; Mukkada V; Putnam P; Naren A; Chehade M; Rothenberg ME; Hogan SP
    J Allergy Clin Immunol; 2020 Jan; 145(1):239-254.e2. PubMed ID: 31647967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solute carrier family 9, subfamily A, member 3 (SLC9A3)/sodium-hydrogen exchanger member 3 (NHE3) dysregulation and dilated intercellular spaces in patients with eosinophilic esophagitis.
    Zeng C; Vanoni S; Wu D; Caldwell JM; Wheeler JC; Arora K; Noah TK; Waggoner L; Besse JA; Yamani AN; Uddin J; Rochman M; Wen T; Chehade M; Collins MH; Mukkada VA; Putnam PE; Naren AP; Rothenberg ME; Hogan SP
    J Allergy Clin Immunol; 2018 Dec; 142(6):1843-1855. PubMed ID: 29729938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 17β-Estradiol protects the esophageal epithelium from IL-13-induced barrier dysfunction and remodeling.
    Wheeler JC; Vanoni S; Zeng C; Waggoner L; Yang Y; Wu D; Uddin J; Karns R; Kottyan L; Mukkada V; Rothenberg ME; Hogan SP
    J Allergy Clin Immunol; 2019 Jun; 143(6):2131-2146. PubMed ID: 30578870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD73
    Hara T; Kasagi Y; Wang J; Sasaki M; Aaron B; Karami A; Shimonosono M; Shimonosono R; Maekawa H; Dolinsky L; Wilkins B; Klein J; Wei J; Nunes K; Lynch K; Spergel JM; Hamilton KE; Ruffner MA; Karakasheva TA; Whelan KA; Nakagawa H; Muir AB
    Cell Mol Gastroenterol Hepatol; 2022; 13(5):1449-1467. PubMed ID: 35108658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial cell-expressed type II IL-4 receptor mediates eosinophilic esophagitis.
    Avlas S; Shani G; Rhone N; Itan M; Dolitzky A; Hazut I; Grisaru-Tal S; Gordon Y; Shoda T; Ballaban A; Ben-Baruch NM; Rochman M; Diesendruck Y; Nahary L; Bitton A; Halpern Z; Benhar I; Varol C; Rothenberg ME; Munitz A
    Allergy; 2023 Feb; 78(2):464-476. PubMed ID: 36070083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophilic esophagitis: Immune mechanisms and therapeutic targets.
    Khokhar D; Marella S; Idelman G; Chang JW; Chehade M; Hogan SP
    Clin Exp Allergy; 2022 Oct; 52(10):1142-1156. PubMed ID: 35778876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profound loss of esophageal tissue differentiation in patients with eosinophilic esophagitis.
    Rochman M; Travers J; Miracle CE; Bedard MC; Wen T; Azouz NP; Caldwell JM; Kc K; Sherrill JD; Davis BP; Rymer JK; Kaufman KM; Aronow BJ; Rothenberg ME
    J Allergy Clin Immunol; 2017 Sep; 140(3):738-749.e3. PubMed ID: 28104354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Filaggrin and tight junction proteins are crucial for IL-13-mediated esophageal barrier dysfunction.
    Wu L; Oshima T; Li M; Tomita T; Fukui H; Watari J; Miwa H
    Am J Physiol Gastrointest Liver Physiol; 2018 Sep; 315(3):G341-G350. PubMed ID: 29746170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic, Inflammatory, and Epithelial Cell Differentiation Factors Control Expression of Human Calpain-14.
    Miller DE; Forney C; Rochman M; Cranert S; Habel J; Rymer J; Lynch A; Schroeder C; Lee J; Sauder A; Smith Q; Chawla M; Trimarchi MP; Lu X; Fjellman E; Brusilovsky M; Barski A; Waggoner S; Weirauch MT; Rothenberg ME; Kottyan LC
    G3 (Bethesda); 2019 Mar; 9(3):729-736. PubMed ID: 30626591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JAK-STAT6 Pathway Inhibitors Block Eotaxin-3 Secretion by Epithelial Cells and Fibroblasts from Esophageal Eosinophilia Patients: Promising Agents to Improve Inflammation and Prevent Fibrosis in EoE.
    Cheng E; Zhang X; Wilson KS; Wang DH; Park JY; Huo X; Yu C; Zhang Q; Spechler SJ; Souza RF
    PLoS One; 2016; 11(6):e0157376. PubMed ID: 27310888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synaptopodin is upregulated by IL-13 in eosinophilic esophagitis and regulates esophageal epithelial cell motility and barrier integrity.
    Rochman M; Travers J; Abonia JP; Caldwell JM; Rothenberg ME
    JCI Insight; 2017 Oct; 2(20):. PubMed ID: 29046486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Esophageal Squamous Cells From Eosinophilic Esophagitis Patients, Th2 Cytokines Increase Eotaxin-3 Secretion Through Effects on Intracellular Calcium and a Non-Gastric Proton Pump.
    Odiase E; Zhang X; Chang Y; Nelson M; Balaji U; Gu J; Zhang Q; Pan Z; Spechler SJ; Souza RF
    Gastroenterology; 2021 May; 160(6):2072-2088.e6. PubMed ID: 33581123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-33 is induced in undifferentiated, non-dividing esophageal epithelial cells in eosinophilic esophagitis.
    Travers J; Rochman M; Caldwell JM; Besse JA; Miracle CE; Rothenberg ME
    Sci Rep; 2017 Dec; 7(1):17563. PubMed ID: 29242581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential Secretion of Thymic Stromal Lymphopoietin (TSLP) by Terminally Differentiated Esophageal Epithelial Cells: Relevance to Eosinophilic Esophagitis (EoE).
    Chandramouleeswaran PM; Shen D; Lee AJ; Benitez A; Dods K; Gambanga F; Wilkins BJ; Merves J; Noah Y; Toltzis S; Yearley JH; Spergel JM; Nakagawa H; Malefyt Rd; Muir AB; Wang ML
    PLoS One; 2016; 11(3):e0150968. PubMed ID: 26992000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial overexpression of IL-33 induces eosinophilic esophagitis dependent on IL-13.
    Masuda MY; Pyon GC; Luo H; LeSuer WE; Putikova A; Dao A; Ortiz DR; Schulze AR; Fritz N; Kobayashi T; Iijima K; Klein-Szanto AJ; Shimonosono M; Flashner S; Morimoto M; Pai RK; Rank MA; Nakagawa H; Kita H; Wright BL; Doyle AD
    J Allergy Clin Immunol; 2024 May; 153(5):1355-1368. PubMed ID: 38310974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered esophageal histamine receptor expression in Eosinophilic Esophagitis (EoE): implications on disease pathogenesis.
    Merves J; Chandramouleeswaran PM; Benitez AJ; Muir AB; Lee AJ; Lim DM; Dods K; Mehta I; Ruchelli ED; Nakagawa H; Spergel JM; Wang ML
    PLoS One; 2015; 10(2):e0114831. PubMed ID: 25723478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen Activator Inhibitor-1 as a Marker of Esophageal Functional Changes in Pediatric Eosinophilic Esophagitis.
    Williamson P; Proudfoot J; Gharibans A; Dohil L; Newbury R; Barsamian J; Hassan M; Rawson R; Katzka D; Kurten R; Dohil R; Mousa H; Aceves S
    Clin Gastroenterol Hepatol; 2022 Jan; 20(1):57-64.e3. PubMed ID: 33007513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysyl Oxidase Regulates Epithelial Differentiation and Barrier Integrity in Eosinophilic Esophagitis.
    Sasaki M; Hara T; Wang JX; Zhou Y; Kennedy KV; Umeweni CN; Alston MA; Spergel ZC; Ishikawa S; Teranishi R; Nakagawa R; Mcmillan EA; Whelan KA; Karakasheva TA; Hamilton KE; Ruffner MA; Muir AB
    Cell Mol Gastroenterol Hepatol; 2024; 17(6):923-937. PubMed ID: 38340809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated IL-33 expression is associated with pediatric eosinophilic esophagitis, and exogenous IL-33 promotes eosinophilic esophagitis development in mice.
    Judd LM; Heine RG; Menheniott TR; Buzzelli J; O'Brien-Simpson N; Pavlic D; O'Connor L; Al Gazali K; Hamilton O; Scurr M; Collison AM; Mattes J; Allen KJ; Giraud AS
    Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(1):G13-25. PubMed ID: 26514775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.